These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24660624)

  • 21. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immune response to HSP70-HBcAg(18-27) complex in HBV transgenic mice].
    Hu HD; Hu P; Chen GL; Peng ML; Chen M; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):28-31. PubMed ID: 17244455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-cytolytic antigen clearance in DNA-vaccinated mice with electroporation.
    Peng JL; Zhao YG; Mai JH; Pang WK; Guo W; Chen GM; Mo GY; Rao GR; Xu YH
    Acta Pharmacol Sin; 2007 Jul; 28(7):1024-30. PubMed ID: 17588339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
    Li L; Tian YJ; Shen H; Zhao XP; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBsAg, HBcAg, and combined HBsAg/HBcAg-based therapeutic vaccines in treating chronic hepatitis B virus infection.
    Akbar SM; Al-Mahtab M; Uddin MH; Khan MS
    Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):363-9. PubMed ID: 23924493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
    Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
    J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mushroom lectin enhanced immunogenicity of HBV DNA vaccine in C57BL/6 and HBsAg-transgenic mice.
    Gao W; Sun Y; Chen S; Zhang J; Kang J; Wang Y; Wang H; Xia G; Liu Q; Kang Y
    Vaccine; 2013 Apr; 31(18):2273-80. PubMed ID: 23499522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Humoral and cellular immunogenecity of genetic vaccine on core gene of hepatitis B virus in mice].
    Huang Z; Lu S; Liu N
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):456-9. PubMed ID: 11715443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant heat shock protein 65 carrying hepatitis B core antigen induces HBcAg-specific CTL response.
    Yang BF; Zhao HL; Xue C; Xiong XH; Zhang W; Yao XQ; Liu ZM
    Vaccine; 2007 May; 25(22):4478-86. PubMed ID: 17467856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
    Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J
    J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
    Zhou Z; Chen WS; Zhang HH; Yao JL
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
    Daemi A; Bolhassani A; Rafati S; Zahedifard F; Hosseinzadeh S; Doustdari F
    Immunol Lett; 2012 Dec; 148(2):117-25. PubMed ID: 23085605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70.
    Peng M; Chen M; Ling N; Xu H; Qing Y; Ren H
    Vaccine; 2006 Feb; 24(7):887-96. PubMed ID: 16446013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
    Shimizu Y; Guidotti LG; Fowler P; Chisari FV
    J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Boosting with HBV subunit particle vaccine enhance immune response of novel DNA vaccine consisting of S-PreS1 fusion gene in mice].
    Chen H; Deng Y; Tan W; Wang W; Guan J; Wen B; Yin X; Ruan L
    Sheng Wu Gong Cheng Xue Bao; 2011 Jan; 27(1):95-100. PubMed ID: 21553495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice.
    Li X; Yang X; Jiang Y; Liu J
    Int Immunol; 2005 Oct; 17(10):1293-302. PubMed ID: 16113237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
    Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
    J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of immune responses to an HBV DNA vaccine by electroporation.
    Luxembourg A; Hannaman D; Ellefsen B; Nakamura G; Bernard R
    Vaccine; 2006 May; 24(21):4490-3. PubMed ID: 16140436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Priming biologically active antibody responses against an isolated, conformational viral epitope by DNA vaccination.
    Riedl P; El-Kholy S; Reimann J; Schirmbeck R
    J Immunol; 2002 Aug; 169(3):1251-60. PubMed ID: 12133946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.